Knockdown of KLK12 inhibits viability and induces apoptosis in human colorectal cancer HT-29 cell line.
Ontology highlight
ABSTRACT: Kallikrein‑related peptidase 12 (KLK12) is overexpressed in cancer tissues including gastric, breast and prostate cancer. However, the role of KLK12 in colorectal cancer is not fully understood. In the present study, the level of KLK12 was determined by performing reverse transcription‑polymerase chain reaction (RT‑qPCR) in colorectal cancer tissues and cell lines. Lipofectamine® 2000 was used to transfect HT‑29 cells to overexpress and knockdown KLK12. Cell viability, migration, invasion and apoptosis were detected by MTT, wound healing, Transwell and flow cytometry assays, respectively. The mRNA and protein expression levels of EMT‑associated proteins, apoptosis‑associated proteins, phosphorylated adenosine monophosphate‑activated protein kinase (p‑AMPK) and phosphorylated mammalian targ
SUBMITTER: Li Q
PROVIDER: S-EPMC6777684 | biostudies-literature | 2019 Nov
REPOSITORIES: biostudies-literature
ACCESS DATA